Literature DB >> 36134014

Optimizing the radiotherapy treatment planning process for glioblastoma.

Rupesh R Kotecha1,2, Minesh P Mehta1,2.   

Abstract

Entities:  

Year:  2022        PMID： 36134014      PMCID： PMC9476971          DOI： 10.1093/nop/npac051

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN： 2054-2577


× No keyword cloud information.
  9 in total

1.  Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging Study.

Authors:  James Stewart; Arjun Sahgal; Young Lee; Hany Soliman; Chia-Lin Tseng; Jay Detsky; Zain Husain; Ling Ho; Sunit Das; Pejman Jabehdar Maralani; Nir Lipsman; Greg Stanisz; James Perry; Hanbo Chen; Eshetu G Atenafu; Mikki Campbell; Angus Z Lau; Mark Ruschin; Sten Myrehaug
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-14       Impact factor: 7.038

2.  Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.

Authors:  M D Piroth; M Pinkawa; R Holy; J Klotz; S Schaar; G Stoffels; N Galldiks; H H Coenen; H J Kaiser; K J Langen; M J Eble
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

3.  Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group.

Authors:  Philipp Karschnia; Jacob S Young; Antonio Dono; Levin Häni; Tommaso Sciortino; Francesco Bruno; Stephanie T Juenger; Nico Teske; Ramin A Morshed; Alexander F Haddad; Yalan Zhang; Sophia Stoecklein; Michael Weller; Michael A Vogelbaum; Juergen Beck; Nitin Tandon; Shawn Hervey-Jumper; Annette M Molinaro; Roberta Rudà; Lorenzo Bello; Oliver Schnell; Yoshua Esquenazi; Maximilian I Ruge; Stefan J Grau; Mitchel S Berger; Susan M Chang; Martin van den Bent; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2022-08-12       Impact factor: 13.029

4.  Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.

Authors:  Javier E Villanueva-Meyer; Seunggu J Han; Soonmee Cha; Nicholas A Butowski
Journal:  J Neurooncol       Date:  2017-05-31       Impact factor: 4.130

5.  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Authors:  Roger Stupp; Sophie Taillibert; Andrew Kanner; William Read; David Steinberg; Benoit Lhermitte; Steven Toms; Ahmed Idbaih; Manmeet S. Ahluwalia; Karen Fink; Francesco Di Meco; Frank Lieberman; Jay-Jiguang Zhu; Giuseppe Stragliotto; David Tran; Steven Brem; Andreas Hottinger; Eilon D. Kirson; Gitit Lavy-Shahaf; Uri Weinberg; Chae-Yong Kim; Sun-Ha Paek; Garth Nicholas; Jordi Bruna; Hal Hirte; Michael Weller; Yoram Palti; Monika E. Hegi; Zvi Ram
Journal:  JAMA       Date:  2017-12-19       Impact factor: 56.272

Review 6.  Standards of care for treatment of recurrent glioblastoma--are we there yet?

Authors:  Michael Weller; Timothy Cloughesy; James R Perry; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2012-11-07       Impact factor: 12.300

7.  The Brain Imaging Collaboration Suite (BrICS): A Cloud Platform for Integrating Whole-Brain Spectroscopic MRI into the Radiation Therapy Planning Workflow.

Authors:  Saumya Gurbani; Brent Weinberg; Lee Cooper; Eric Mellon; Eduard Schreibmann; Sulaiman Sheriff; Andrew Maudsley; Mohammed Goryawala; Hui-Kuo Shu; Hyunsuk Shim
Journal:  Tomography       Date:  2019-03

8.  Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.

Authors:  Michelle M Kim; Hemant A Parmar; Madhava P Aryal; Charles S Mayo; James M Balter; Theodore S Lawrence; Yue Cao
Journal:  Tomography       Date:  2019-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.